Tonsillectomy and the Risk of Inflammatory Bowel Disease: A Retrospective Cohort Study Using Real-World US Data

Area of Science:

• Gastroenterology
• Immunology
• Surgical Outcomes

Background:

• Inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn's disease (CD), involves complex immune dysregulation.
• Factors contributing to IBD include genetics, environment, and compromised gut barrier function.

Purpose of the Study:

• To investigate the association between tonsillectomy, an immune-modulating surgery, and the subsequent risk of IBD development.
• To evaluate the impact of tonsillectomy on the incidence of both CD and UC.

Main Methods:

• A retrospective cohort study utilizing the TriNetX research network (2005-2023) with over 124 million individuals.
• 1,420,302 participants were matched 1:1 using propensity score matching (PSM) based on numerous covariates.
• Incidence of IBD (CD and UC) was the primary outcome, analyzed using adjusted hazard ratios (HR).

Main Results:

• Tonsillectomy was significantly associated with an increased risk of developing IBD (HR, 1.30; 95% CI, 1.14-1.47).
• Elevated risks were observed for both Crohn's disease (HR, 1.37) and ulcerative colitis (HR, 1.29).
• The increased IBD risk was consistent across various demographic subgroups and confirmed in sensitivity analyses.

Conclusions:

• A significant association exists between tonsillectomy and an elevated risk of developing IBD.
• These findings suggest tonsillectomy may influence long-term gastrointestinal health.
• Further research is warranted to elucidate the underlying mechanisms and explore preventative strategies.